Clinuvel Pharmaceuticals Ltd.
Clinuvel Pharmaceuticals Ltd. (NASDAQ: CUVL) is trading at $5.63, about ₹540 at today's USD/INR rate, as of 25 Sep 2026, 4:00 PM ET, down 2.60% today. Indian residents can buy Clinuvel Pharmaceuticals from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$5.60
Today's high
$5.82
52 week low
$5.60
52 week high
$8.92
CUVL opened at $5.82, closed previously at $5.78, and has traded between $5.60 and $8.92 over the past 52 weeks.
About
Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue; and PRÉNUMBRA, a liquid injectable formulation of afamelanotide. It is also developing NEURACTHEL (ACTH), an adrenocorticotropic hormone for targeting neurological, endocrinological, and degenerative disorders; and pharmaceutical formulations melanocortin technology for the treatment of a range of disorders. In addition, the company provides photocosmetic products for individuals and populations at risk of exposure to ultraviolet and high energy visible light, and in need of assistance in DNA repair and melanogenesis of the skin. The company was incorporated in 1999 and is headquartered in Melbourne, Australia.
Key statistics
Avg. volume
13.04K
Market cap
$283.91M
P/E Ratio
—
Price-to-sales ratio
—
Enterprise value
—
Free cash flow yield
—
Debt-to-equity ratio
—
Return on equity
—
ROIC
—
Beta
0.57
Dividend yield
—
Last dividend
$0.03
Financial overview
Revenue
—
Earnings per share
—
Free cash flow
—
Net profit margin
—
Gross margin
—
EBITDA
—
Revenue growth
—
How to buy Clinuvel Pharmaceuticals from India
Indian residents can buy Clinuvel Pharmaceuticals shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for Clinuvel Pharmaceuticals and place an order
Find Clinuvel Pharmaceuticals by name or by its ticker, CUVL, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Clinuvel Pharmaceuticals trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Clinuvel Pharmaceuticals position in USD and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in Clinuvel Pharmaceuticals from India
Trading and taxes when buying Clinuvel Pharmaceuticals from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
FAQs
Can Indian residents buy Clinuvel Pharmaceuticals stock?
Yes. Clinuvel Pharmaceuticals (CUVL) has been listed on NASDAQ since 2026, in the Medical - Pharmaceuticals industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one Clinuvel Pharmaceuticals share cost in rupees?
One Clinuvel Pharmaceuticals share is $5.63 — about ₹540 at a USD/INR rate of 95.92 on 25 Sep 2026. Both the Clinuvel Pharmaceuticals price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Clinuvel Pharmaceuticals from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy whole shares of Clinuvel Pharmaceuticals?
Yes. One Clinuvel Pharmaceuticals share is $5.63, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Clinuvel Pharmaceuticals.
How are gains on Clinuvel Pharmaceuticals shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Clinuvel Pharmaceuticals price. Paasa issues a capital-gains statement for your return.
Does Clinuvel Pharmaceuticals pay a dividend, and how is it taxed in India?
Yes. Clinuvel Pharmaceuticals pays a dividend — the most recent was $0.03 per share, about ₹2.75. Dividends are taxed at your slab rate in India. Paasa's dividend report covers each payment.
When can I trade Clinuvel Pharmaceuticals from India?
NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is Clinuvel Pharmaceuticals a United States company, and does that change how it is taxed?
Clinuvel Pharmaceuticals trades on NASDAQ in US dollars, but the company is domiciled in Australia. Clinuvel Pharmaceuticals trades as an American Depositary Receipt rather than an ordinary share. Some non-US companies list in the US through American Depositary Receipts, which can carry dividend withholding at the company's home-country rate. Your India-side capital-gains treatment is the same either way.
Do I have to declare Clinuvel Pharmaceuticals shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Clinuvel Pharmaceuticals holding, its cost and its closing value.
How do I sell Clinuvel Pharmaceuticals and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.